myristicin and ferulic acid

myristicin has been researched along with ferulic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brindis, F; Bye, R; González-Andrade, M; Mata, R; Rodríguez, R	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1

Other Studies

2 other study(ies) available for myristicin and ferulic acid

Article	Year
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor. Journal of natural products, 2011, Mar-25, Volume: 74, Issue:3 Topics: Acarbose; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Secretion; Ligusticum; Medicine, Traditional; Mexico; Mice; Phthalic Anhydrides; Stereoisomerism; Streptozocin	2011
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012

Article

Year

(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.

Journal of natural products, 2011, Mar-25, Volume: 74, Issue:3

Topics: Acarbose; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Secretion; Ligusticum; Medicine, Traditional; Mexico; Mice; Phthalic Anhydrides; Stereoisomerism; Streptozocin

2011

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012